What impact do the new direct acting antiviral drugs have on the patients’ quality of life?
Marta Gentili(Luigi Sacco Hospital), Giuliano Rizzardini, E. Cesari, Sonia Radice(Luigi Sacco Hospital), Simona Landonio(ASST Fatebenefratelli Sacco), V Scalzi(ASST Fatebenefratelli Sacco), Stefania Vimercati(Qinetiq (United Kingdom)), Daniele Cattaneo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Monica Schiavini(ASST Fatebenefratelli Sacco), C. Magni(ASST Fatebenefratelli Sacco), Emilio Clementi(Luigi Sacco Hospital), F. Niero(University of Milan), Carla Carnovale(Luigi Sacco Hospital)
Cited by 0
Related Papers
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|589
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
|Proceedings of the National Academy of Sciences|2004|496
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
|Cell Death and Disease|2012|265
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
|New England Journal of Medicine|2022|264
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133